Engineered regulatory T cell therapies
With Regeneron, the company discovers, develops, and commercializes novel regulatory T cell therapies.
Source: LinkedIn company description · Retrieved October 13, 2026
Sonoma Biotherapeutics is a South San Francisco- and Seattle-based clinical-stage biotechnology company.
The company develops engineered regulatory T cell therapies for serious autoimmune and inflammatory diseases. Sonoma Biotherapeutics partners with Regeneron to discover, develop, and commercialize regulatory T cell therapies.
Based on the company’s public LinkedIn information, supplied through RevenueBase.
With Regeneron, the company discovers, develops, and commercializes novel regulatory T cell therapies.
Source: LinkedIn company description · Retrieved October 13, 2026
Supported appearances on published RevenueBase lists, including available memberships beyond displayed rankings.
Positions describe ordering within each source list. See how lists are built ↗
Embeddable award for your website
RevenueBase prepared this profile from the company’s public LinkedIn information and RevenueBase company data. These source records were retrieved on October 13, 2026. AI helped summarize these sources, with a separate automated check against the source text completed on November 3, 2026. Directory positions use company-contact counts from separate saved list snapshots dated September 14, 2026, September 15, 2026, September 17, 2026, September 18, 2026, September 19, 2026, September 26, 2026 and September 30, 2026. How the company lists are built.
Share a correction, your relationship to the company, and supporting sources. Requests are reviewed before changes are published.
Explore more companies by name, headquarters and business focus.